• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Prometic Life Sciences Inc

+ Add to Watchlist


1.250 EUR 0.0000.00%

As of 09:31:31 ET on 09/19/2014.

Snapshot for Prometic Life Sciences Inc (PJ2)

Open: - Day's Range: - Volume: 6,437
Previous Close: 1.250 52wk Range: 0.513 - 1.250 1-Yr Rtn: +180.90%

Stock Chart for PJ2

No chart data available.
  • PJ2:GR 1.250
  • 1D
  • 1M
  • 1Y
Interactive PJ2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PJ2

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -0.0100
Est. PEG Ratio -
Market Cap (M EUR) 662.86
Shares Outstanding (M) 530.29
30 Day Average Volume 1,082
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PJ2

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for PJ2

ProMetic Life Sciences, Inc. is an international bio-pharmaceutical company. The Company, through its subsidiaries, researches, develops, manufactures and markets a variety of commercial applications from its core technology. ProMetic's applications are used in therapeutics, large-scale drug purification, chemical genomics and proteomics, drug delivery and drug development.

Pierre LaurinPresident/CEO/FounderBruce PritchardCFO/Interim COO
John MoranChief Medical OfficerFrederic DumaisDir:Communications & Investor Relations
More Company Profile & Key Executives for PJ2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil